COVID-19
  • Article
  • May 15 2020

Public Health Dean Donna Arnett is a panel participant for the ASPPH Virtual Annual Meeting, focused on lessons learned during the COVID-19 pandemic.

  • Article
  • May 15 2020

“Our results suggest that light measures don’t work, and strong measures do," said Charles Courtemanche.

  • Article
  • May 14 2020

For the RAPID project, the team will create a membrane mask and other flat sheet materials with a more porous and spongy structure that will include charged domain and enzymes, which would capture and effectively deactivate SARS-CoV-2, the virus that causes COVID-19.

  • Article
  • May 13 2020

A group of UK professors and scientists efforts to identify possible direct therapeutic approaches to treat COVID-19 was published in the Perspectives section of the most recent issue of Science, a journal of the American Association for the Advancement of Science (AAAS).

  • Article
  • May 11 2020

UK researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means. The research is part of UK’s CURE Alliance team, which is uniting UK researchers across disciplines in the fight against the novel coronavirus.

  • Article
  • May 7 2020

“We are pleased to be able to offer this clinical trial to patients with COVID-19 in Kentucky. While there is no standard treatment for COVID-19, this trial gives us the ability to test multiple therapies rapidly in order to identify the most promising agents.”

  • Article
  • May 5 2020

The Kentucky Conference on Health Communication (KCHC), which was supposed to be held April 2-4, 2020, at the Hyatt Regency in Lexington, made the swift change to a virtual conference amid the COVID-19 pandemic.

  • Article
  • Apr 30 2020

According to the report, confirmed COVID-19 cases in the Commonwealth would have reached a staggering 45,000 by April 25 without any state-imposed measures. For comparison, the current total of confirmed COVID-19 cases is fewer than 4,000.

  • Article
  • Apr 28 2020

The UK CURE Alliance, in collaboration with the UK Center for Clinical and Translational Science, has issued RFAs for COVID-19 funding in three categories: health, materials and methods and social sciences. Full-time UK faculty in all title series are eligible to apply.

  • Article
  • Apr 27 2020

Sutton is the first UK researcher to receive funding for COVID-19 related work as part of the NSF's Rapid Response Research (RAPID) grant program, which enables the agency to quickly process and support research that addresses an urgent need.